According to a report from Deloitte Touche Tohmatsu, chemical companies’ profits will continue to fall unless new approaches are adopted. The report is based on the analysis of 1998–2008 financial results for 231 publicly held chemical firms. Gross margins for 35 commodity-chemical providers declined from 28% in 1998 to 16.5% in 2007. Commodity-chemical suppliers are […]
Global R&D spending is expected to grow 4.0% in 2010 to $1,156.5 billion, following a 1.0% decline in 2009, according to Battelle and R&D Magazine. China’s R&D spending rose 21.0% to account for 11.1% of worldwide R&D spending in 2009, while R&D expenditures in India increased 5.2% to account for 2.5%. R&D spending in Asia […]
Gartner estimates that semiconductor industry capital spending will decrease 42.6% in 2009 to $25,272 million. However, next year, the industry’s capital spending is forecasted to rebound, growing 45.3% to $36,728 million due to technology upgrades. Capital equipment spending by the semiconductor sector is expected to decline 46.8% to $16,297 million in 2009. In 2010, it […]
Department of Health and Human Services (HHS) Secretary Kathleen Sebelius has announced that the HHS will undertake a review of US government policies for vaccine development and responses to public health issues. The review will be completed early next year. The review will focus on improving vaccine production, which has most recently led to shortages […]
According to a new report from PricewaterhouseCoopers (PwC), the US market for personalized medicine will have a compound annual growth rate of 11% between 2009 and 2015. The market is currently estimated at $225–$232 billion and is expected to reach $344–$452 billion by 2015. PwC defines personalized medicine as: “products and services that leverage the […]
The World Health Organization estimates that the swine flu has claimed 6,250 lives. The Americas shows the highest rate of death with 4,512 people having died from the virus. In the US alone, new estimates from the Centers for Disease Control and Prevention put the total number of fatalities at 3,900. The spread of the […]
Although prospects for the mining industry have improved from a year ago, its most recent gains remain precarious. Some observers assert that the demand for metals from China and other developing countries is returning and will remain strong, with the effects of the global economic slowdown having only temporary effect. Rio Tinto estimates that global […]
US sales of biologics increased 4.5% last year to about $46.5 billion, down from historical double-digit growth due to safety concerns and market saturation. Among the nine classes of biologics, the largest therapeutic class, with 35% of the market, remains monoclonal antibodies (mAbs). US sales of mAbs increased an estimated 13% in 2008, down from […]
AVOS Life Sciences estimates that by 2013, biologics will account for 40% of the 14 major drug companies’ portfolios of branded drugs with more than $500 million in yearly sales, up from 26% last year. For the period, both GlaxoSmithKline (GSK) and Abbott will be among the top three firms in terms of sales and […]
According to a report commissioned by the Coca-Cola Retailing Research Council Asia and prepared by McKinsey & Company, retailers in Asia should be more active in setting standards for food safety and freshness. To contain threats, retailers need a management framework for their entire supply chain. Retailers should also focus on so-called “hot spots,” where […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
